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At 33 years of age he underwent successful valve repair for
severe mitral regurgitation.
Follow-up echocardiography showed severe left ven-
tricular dilatation and severe systolic dysfunction with
hyper-trabeculation of the lateral wall, suggestive of isolated
ventricular non–compaction. Anti–heart failure treatment
was optimised and atypical causes of heart failure were con-
sidered. Genetic testing was performed on a panel of 174
cardiac disease genes. This identified a heterozygous variant
in the COL3A1 gene (c.2959G>A, p.Gly987Ser), confirming a
diagnosis of vascular Ehlers-Danlos syndrome.
http://dx.doi.org/10.1016/j.hlc.2018.06.060
0060
A Curious Case of Environmental
Cardiomyopathy
A. Al-Omary ∗, A. Bhat, B. Changsiri, A.
Denniss
Blacktown Hospital, Blacktown, Australia
We present a unique case of a temporal relationship of car-
diomyopathy in an unrelated husband and wife couple. A
39-year-old man presented to our institution with a subacute
history of dyspnoea, with clinical features of biventricular
heart failure. There were no antecedent triggers bar a remote
history of a viral infection several months prior and the
patient had no family history of cardiac disease. Transthoracic
echocardiography demonstrated severe biventricular systolic
impairment (left ventricular ejection fraction 17%) with evi-
dence of severe spontaneous echo contrast in the left ventricle.
Coronary angiography revealed minor coronary disease.
Right ventricular biopsy revealed myocyte hypertrophy with
interstitial fibrosis. He was treated with heart failure-specific
therapy and discharged for follow-up. Unfortunately, his 28-
year-old wife, who was >6 months postpartum, had a similar
presentation to our institution with examination findings of
right-sided heart failure 2 months after the husband’s index
presentation. Similarly, the only antecedent triggers identi-
fied were of a possible viral illness several months predating
her presentation. Transthoracic echocardiography revealed
severe biventricular systolic impairment (left ventricular ejec-
tion fraction 23%). Coronary angiography revealed normal
coronary arteries. Right ventricular biopsy similarly revealed
mild myocyte hypertrophy with mild interstitial fibrosis. She
was treated with heart failure-specific therapy and similarly
discharged. Both of them were given a diagnosis of idiopathic
dilated cardiomyopathy. This case emphasises the impor-
tance of potential environmental factors in the aetiology of
idiopathic cardiomyopathy and the value of further research
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Background: Thirst is a burdensome symptom of chronic
heart failure (CHF). To date, there remains limited scientific
evidence to advise clinicians on how to manage thirst in daily
clinical practice. RELIEVE-CHF is the first trial to investigate
the use of chewing gum to relieve thirst in CHF. The aim
of this study was to determine the effect of chewing gum
on the level of thirst, weight stability, and quality of life on
individuals with CHF.
Methods: A total of 71 individuals with CHF on oral loop
diuretics were recruited from St. Vincent’s Hospital Sydney.
Thirty-six participants were randomised to chewing gum
(54 ± 14 years; 61% men) and 35 to no chewing gum (54 ± 15
years; 66% men) for 2 weeks. Both groups were assessed for
their level of thirst (using a visual analogue scale and numeric
rating scale) and weight at days 1–4, 7, 14, and 28, and quality
of life at day 28.
Results: Those who received chewing gum had a statis-
tically significant improvement in the level of thirst at day
4 (Figure 1A [p = 0.04]; Figure 1B [p = 0.019]) and day 14
(Figure 1C [p = 0.02]; Figure 1D [p = 0.021]) compared to those
who did not. No group differences were observed in weight




Conclusion: Chewing gum provided relief from thirst but
did not influence weight or quality of life.
http://dx.doi.org/10.1016/j.hlc.2018.06.062
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A Rare Case of Infiltrative Cardiomyopathy
Secondary to Scleromyxoedema
C. Khandkar ∗, K. Vaidya, R. Penglase, K.
Cai, J. Shin, I. Hunyor, A. Keech, N. McGill
Royal Prince Alfred Hospital, Sydney, Australia
A 44-year-old woman with a history of treatment-refractory
scleromyxoedema presented with clinical heart failure along
with dyspnoea and orthopnoea. Her previous transthoracic
echo (TTE) 3 months prior showed normal left ventricular
(LV) and right ventricular (RV) function with a stable pleural
effusion. She had a raised N-terminal pro-B-type natriuretic
peptide and creatinine kinase of 773 pmol/L and 4534 U/L,
respectively. Her TTE showed new biventricular dysfunc-
tion, with diffuse hypokinesis and a LV ejection fraction
(EF) of 20–25%. She underwent a coronary angiogram with
right heart studies, which ruled out ischaemic cardiomy-
opathy or pulmonary hypertension. A cardiac magnetic
resonance imaging (cMRI) confirmed biventricular failure
(LVEF 37%; RVEF 28%) with the known stable pleural
effusion (Figure 1A). Late gadolinium-enhanced images
on cMRI showed diffuse patchy enhancement consistent
with infiltrative disease. An endomyocardial biopsy showed
myocarditis with interstitial fibrosis. There was polymor-
phous inflammatory infiltrate with accompanying myocyte
damage. Interstitial mucin deposition was later confirmed
with a colloidal iron stain, a hallmark of scleromyxedema.
A thigh MRI and biopsy showed a necrotising myositis,
confirming systemic disease. She responded to high-dose
prednisolone, thalidomide, and intravenous immunoglob-
ulin. Her follow up TTE showed stable LV function and
improved RV function.
Figure 1.
This is the first documented case of biventricular failure sec-
ondary to scleromyxedema, with correlating endomyocardial
biopsy and cMRI results. This case illustrates the diagnosis
and possible treatment of a rare infiltrative cardiomyopathy,
for which evidence in current literature is scarce.
http://dx.doi.org/10.1016/j.hlc.2018.06.063
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A 32-year-old woman had multiple presentations to the
emergency department with severe abdominal pain and vom-
iting in context of a previous diagnosis of endometriosis
with multiple endometrial ablations. Cardiology was con-
sulted for sinus tachycardia. She had no electrocardiogram
changes and had an initial Hs-trop of <5, peaking later at 200.
An echocardiogram revealed severe left ventricular dysfunc-
tion with apical hyperkinesis and circumferential akinesis
of the mid and basal ventricle. Cardiac magnetic resonance
imaging revealed no evidence of myocardial oedema or fibro-
sis. Computed coronary angiogram was entirely normal.
In the interim, the patient had an extensive work-up and
multidisciplinary reviews for her abdominal pain, with no
obvious cause. The diagnosis was suspected when a urine
sample awaiting collection by the bedside turned red. Uri-
nary porphobilinogen and porphyrins were highly elevated.
Molecular genetic testing confirmed HMBS mutation, asso-
ciated with acute intermittent porphyria. The patient was
started on intravenous haema-arginate with resolution of
symptoms. Serial transthoracic echocardiograms over the
next 2 weeks revealed normalisation of left ventricular func-
tion. The patient continues to receive human hemin injections
regularly and has had no further cardiac issues.
Conclusion: Reverse Takotsubo is a rare variant of Takot-
subo cardiomyopathy, forming only 2.2% of the cases
reported in the International Takotsubo Registry [1]. This case
highlights an atypical presentation of a rare condition in con-
text of an exceedingly rare condition. Methodical work-up
and attention to detail have yielded an important diagnosis
after remaining elusive for many years.
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